APOA1 and serum lipopolysaccharide activity: This modest trend in TGs is consistent with the relatively low TGs at baseline and published effects of fenofibrate in such settings.24 In contrast, 6 to 8 weeks of fenofibrate had no effect on HDL, phospholipids, or apolipoprotein A-I compared to placebo before endotoxemia.